German wireline provider uses IP Infusion OcNOS® and Edgecore hardware for interoperability and expandability
SANTA CLARA, Calif., November 6, 2024 – IP Infusion, the market leader in carrier-grade networking software systems, announced today that AnschlussWerk, a wireline network provider based in Germany, has deployed OcNOS software and Edgecore hardware for backbone and aggregation networking. OcNOS è stato selezionato per la sua capacità di garantire interoperabilità con le soluzioni esistenti ed espandibilità flessibile.
AnschlussWerk utilizzerà una combinazione di prodotti software IP Infusion Aggregation Router installati su Edgecore 300G Cell Site Router e Aggregation Router 2.4T. The 300G router will aggregate traffic for 10G and smaller bandwidth customers in its regional PoPs. The 2.4T OcNOS Aggregation Routers will perform peering and traffic aggregation to its regional PoPs and large bandwidth customers.
"IP Infusion's OcNOS software with Edgecore hardware were selected for providing a compelling set of features to accommodate our rapid growth," said Werner Rades, CEO of AnschlussWerk. "OcNOS provides an easy and common platform across different use cases, with an upgrade path from existing solutions."
"Performance networking software is becoming increasingly relevant to harness the benefits of open networking," said Atsushi Ogata, President and CEO of IP Infusion. "As a specialist networking software vendor for over twenty years, IP Infusion has helped create this entire market sector."
Chi è IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
About AnschlussWerk
AnschlussWerk is providing Internet, telephony and video services as well as connectivity services to other services providers. With it's primary service region in Bavaria, Germany AnschlussWerk is strong partner to reach regional centers and rural areas with it's independent infrastructure. Additionally AnschlussWerk supports infrastructure owner and service providers as a managed service provider by operating their telecommunication network and delivering services to their customers.
AnschlussWerk is based in Traunstein, Bavaria, Germany. More information can be found at https://www.anschlusswerk.de.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
Chi è IP Infusion
IP Infusion è un fornitore leader di software di open networking e offre OcNOS, un sistema operativo di rete carrier-grade per service provider, data center e reti fabric AI. Con esperienza nel networking dal 1999 e oltre 600 operatori nel mondo, IP Infusion abilita un'infrastruttura di rete aperta, multi-vendor, efficiente nei costi e flessibile su hardware aperto validato di partner come Edgecore Networks, UfiSpace e Celestica. IP Infusion è una controllata al 100% di ACCESS CO., LTD. (Borsa di Tokyo: 4813).
Contatto stampa
For press inquiries, analyst briefings, or media materials, please contatti il nostro team or email pr@ipinfusion.com.
Dichiarazioni previsionali
Questo comunicato può contenere dichiarazioni previsionali relative a prodotti, tecnologie e piani di IP Infusion. Le dichiarazioni previsionali si basano sulle informazioni disponibili alla data di pubblicazione e comportano rischi e incertezze. I risultati effettivi possono differire. Piani di prodotto, funzionalità, tempistiche di rilascio e disponibilità sono soggetti a modifiche senza preavviso e non costituiscono un impegno, una promessa o un obbligo legale. IP Infusion non assume alcun obbligo di aggiornare le dichiarazioni previsionali.